Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks
Description
CONCLUSION: We found that 8 of the 30 drugs identified by graph-based scoring on complemented networks as potential candidates for COVID-19 repurposing were additionally supported by real-world patient data in follow-up analyses. These results show
